NCT01315379

Brief Summary

The purpose of this study is to determine whether Prolonged Exposure Therapy (PE)is effective in the treatment of post-traumatic stress symptoms in children and adolescents with mild traumatic brain injury (m-TBI) due to motor vehicle accident.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Apr 2011

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 3, 2011

Completed
12 days until next milestone

First Posted

Study publicly available on registry

March 15, 2011

Completed
17 days until next milestone

Study Start

First participant enrolled

April 1, 2011

Completed
5.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2017

Completed
Last Updated

October 11, 2016

Status Verified

October 1, 2016

Enrollment Period

5.9 years

First QC Date

March 3, 2011

Last Update Submit

October 9, 2016

Conditions

Keywords

Prolonged ExposureCBTPTSDMild Traumatic Brain InjuryPost Concussive Syndrome

Outcome Measures

Primary Outcomes (1)

  • Percentage of participants with PTSD diagnosis as a measure of recovery rates

    Psychological evaluation using the Hebrew translation of the Childhood version of the Schedule for Affective Disorders and Schizophrenia (Apter et al., 1989).

    After up to 18 weeks of PE treatment

Secondary Outcomes (9)

  • Change from Baseline in Neuropsychological Functioning at Treatment Completion

    After up to 18 weeks of treatment

  • Change from Baseline in The Child PTSD Symptoms Scale at Treatment Completion

    At up to 18 weeks of PE treatment

  • Change from Baseline in The Child PTSD Symptoms Scale at 2 weeks Follow Up

    2 weeks following treatment completion

  • Change from Baseline in The Child PTSD Symptoms Scale at 4 weeks Follow Up

    4 weeks following treatment Completion

  • Change from Baseline in The Child PTSD Symptoms Scale at 12 weeks Follow Up

    12 weeks following treatment completion

  • +4 more secondary outcomes

Study Arms (2)

PTSD without TBI

children and adolescents with a diagnosis of PTSD and without head injury, following a motor vehicle accident. This group will be treated using the Prolonged Exposure Therapy protocol.

Behavioral: Prolonged Exposure Therapy

PTSD with m-TBI

children and adolescents with a diagnosis of PTSD and a diagnosis of mild traumatic brain injury, following a motor vehicle accident. This group will be treated using the Prolonged Exposure Therapy protocol.

Behavioral: Prolonged Exposure Therapy

Interventions

This intervention comprises 12-18 sessions of cognitive behavior therapy for PTSD with the components (a) Psychological education, (b) in vivo exposure (c) prolonged imaginal exposure, (d) cognitive restructuring (e) summary and relapse prevention.

PTSD with m-TBIPTSD without TBI

Eligibility Criteria

Age6 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Sixty children age 6 to 18 attending the Anxiety clinic in Schneider Children's Medical Center of Israel, following MVA, will be included.

You may qualify if:

  • For the whole sample:
  • Children age 6 to 18
  • Language spoken: Hebrew, Arabic
  • DSM- IV R diagnosis: PTSD
  • Car accident event within past 3 years
  • For the m-TBI group:
  • Any of the following symptoms or experiences occurring during or shortly after the accident: loss of consciousness, dazed, confused, saw stars, headache, dizziness, irritability, memory gap (not remembering injury or injury period), visual loss, abdominal pain\].
  • Diagnosis of MTBI within 3 years as confirmed by CT/MRI/fMRI.
  • Glasgow coma scale; GCS\<15.

You may not qualify if:

  • Children presenting with psychotic symptoms
  • Children presenting with mental retardation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Schneider Children's Medical Center of Israel

Petah Tikva, Israel

RECRUITING

MeSH Terms

Conditions

Stress Disorders, Post-TraumaticBrain Injuries, TraumaticPost-Concussion SyndromeBrain Concussion

Condition Hierarchy (Ancestors)

Stress Disorders, TraumaticTrauma and Stressor Related DisordersMental DisordersBrain InjuriesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesCraniocerebral TraumaTrauma, Nervous SystemWounds and InjuriesHead Injuries, ClosedWounds, Nonpenetrating

Study Officials

  • Maayans Shorer, PhD

    Rabin Medical Center

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Maayan Shorer, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 3, 2011

First Posted

March 15, 2011

Study Start

April 1, 2011

Primary Completion

March 1, 2017

Study Completion

March 1, 2017

Last Updated

October 11, 2016

Record last verified: 2016-10

Data Sharing

IPD Sharing
Will not share

Locations